We are pleased to see that our latest incretin medicine meets our expectations for safety and tolerability, glucose control and weight loss, and we look forward to additional data readouts later this year," remarked David Ricks, Eli Lilly Chair and CEO
They are challenging on the resource front, especially given that the problem applies to more than just semaglutide
Researchers administered intravenous DSIP to insomnia patients over several days and conducted polysomnographic sleep studies to objectively measure sleep architecture changes including time to sleep onset, total sleep time, and sleep stage distribution
Gastroparesis, with its symptoms of nausea, vomiting, bloating, and abdominal pain, can exacerbate the discomfort and decrease the quality of life